Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    PBDr. Paul Blair

    Dr. Paul Blair

    Infectious Disease · General Infectious Disease
    Vanderbilt University
    paulblair

    Research

    RNAemia and Severe COVID-19: Candidate Treatment Targets Identified Through Transcriptomics

    2026

    Via J Infect Dis

    Research

    Locally acquired hantavirus infection in Maryland presenting with fever and headache

    2026

    Via The American Journal of Medicine

    Research

    Long-Term Mortality among Hospitalized Adults with Sepsis in Uganda: A Prospective Cohort Study

    2026

    Via The American Journal of Tropical Medicine and Hygiene

    Mar 17, 2026Journal Article

    Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024.

    ​

    Written by 1 Roon author & 60 others

    Via Clinical Infectious Diseases
    Mar 17, 2026Journal Article

    Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.

    ​
    ​
    ​+1

    Written by 3 Roon authors & 43 others

    Via Clinical Infectious Diseases

    Research

    Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19

    2026

    Via JAMA Network Open

    Research

    Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda

    2025

    Via Emerging Infectious Diseases

    Research

    Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023

    2025

    Via Influenza and Other Respiratory Viruses

    Research

    Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025

    2025

    Via medRxiv

    Research

    Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae

    2025

    Via The Journal of Infectious Diseases

    Aug 1, 2025Journal Article

    Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.

    ​
    ​
    ​+2

    Written by 4 Roon authors & 53 others

    Via Clinical Infectious Diseases

    Research

    Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination

    2025

    Via JAMA Network Open

    Research

    Comparison of Immunization Information Systems, Electronic Medical Records, and Self-Report to Ascertain RSV Vaccination Status Among US Adults Aged ≥60 Years, 2023-2024

    2025

    Via Vaccine

    Research

    Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024

    2025

    Via The Journal of Infectious Diseases

    Research

    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons

    2025

    Via JAMA